Latest News
Mar 30,2021
Feb 15,2021
Oct 06,2020
Don't Miss News
Neuren Australian Clinical Trial
admin Mar 30,2021Welcome to Neuren Pharmaceuticals (www.neurenpharma.com; ASX:NEU). Neuren is a Melbourne-based company at the forefront of efforts to develop effective treatments for rare, paediatric neurodevelopmental disorders. Over the last few years, they’ve successfully steered their first drug (Trofinetide) into Phase 3 clinical trials (the last stage before approval) for the treatment of Rett syndrome. The final …
Centre of Excellence
Feb 15,2021
Angelman syndrome biobank
Oct 06,2020
Roche Clinical trial
Jun 23,2020Other News
Global Angelman Syndrome Registry collaboration
Dec 20,2019We are proud to collaborate with the Angelman Syndrome Foundation, the Dup15q Alliance in Linking Angelman and Dup15q Data for Expanded Research (LADDER).
You May Have Missed
